Prior to current studies on the emergence of drug resistance with the introduction of antiretroviral therapy (ART) in Cameroon, we performed genotypic analysis on samples from drug-naïve, human immunodeficiency virus (HIV)-infected individuals in this country. Of the 79 HIV type 1 (HIV-1) pol sequences analyzed from Cameroonian samples, 3 (3.8%) were identified as HIV-1 group O, 1 (1.2%) was identified as an HIV-2 intergroup B/A recombinant, and the remaining 75 (95.0%) were identified as HIV-1 group M. Group M isolates were further classified as subtypes A1 (n ؍ 4), D (n ؍ 4), F2 (n ؍ 6), G (n ؍ 12), H (n ؍ 2), and K (n ؍ 1) and as circulating recombinant forms CRF02_AG (n ؍ 41), CRF11_cpx (n ؍ 1), and CRF13_cpx (n ؍ 2). Two pol sequences were identified as unique recombinant forms of CRF02_AG/F2 (n ؍ 2). M46L (n ؍ 2), a major resistance mutation associated with resistance to protease inhibitors, was observed in 2/75 (2.6%) group M samples.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.